Q&A: Norwegian Researchers Evaluate Array Platforms for Profiling Bone Tumors

According to the study's findings, the major vendors' platforms performed well in terms of reproducibility, but Agilent's microarrays showed better linearity and dynamic range.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.